Navigation Links
Shimadzu’s New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Analysis
Date:12/17/2013

Columbia, MD (PRWEB) December 17, 2013

Identifying SVP (sub-visible particle) aggregates that can cause severe side effects in biopharmaceuticals has been a longtime concern in the pharmaceutical industry. Shimadzu Scientific Instruments has introduced the Aggregates Sizer Aggregation Analysis System, which offers the first effective quantitative, high-speed evaluation of 100 nm to 10µm SVP aggregates that may be present in biopharmaceuticals.

Generation of aggregates in the sub-visible range can occur during development of biopharmaceuticals because of mechanical stimulation or temperature changes. The Aggregates Sizer is capable of covering all ranges of SVP particle size in a single measurement, and can evaluate the concentration (µg/mL) that can induce allergic systemic reactions such as anaphylaxis and other severe side effects.

The new system offers greater quality control and improved efficiency in the development of biopharmaceuticals. By enabling screening for and elimination of aggregation prone-proteins in the early stages of drug development, Shimadzu’s Aggregates Sizer will save time and reduce costs.

The Aggregates Sizer also features greater sensitivity and speed than previous size analyzers. The instrument is capable of accurately measuring micro sample quantities using disposable cells for 0.4 mL sample quantities. Size and quantity changes can be confirmed quantitatively as a concentration (unit: µg/mL) at one-second intervals, allowing real-time evaluation of rates of change and observation of aggregation processes as samples are mechanically stimulated.

Shimadzu offers a variety of software and system configuration options for a broad range of uses, environments and conditions. For more information, visit http://www.shimadzu.com/an/lifescience/bio/aggregates-sizer.html .

About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support. Visit http://www.ssi.shimadzu.com for more information.

# # #

Read the full story at http://www.prweb.com/releases/2013/12/prweb11431762.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Shimadzu’s New Triple Quadrupole LCMS-8050 Mass Spectrometer Offers Combination of Outstanding Sensitivity With Ultra-fast, Accurate Analysis
2. Alacrita Aggregates the Life Science Practices of Two Consulting Firms and Appoints Simon Turner Ph.D FRSC as Partner
3. Peptide Machines, Inc. Introduces New High-Quality, Cost-Efficient, Fully Automated Multiple Peptide Synthesizer with Preactivation
4. Americas Pharmaceutical Market Forecasts to 2018
5. Industry Shares, Size, Trend, Analysis, and Forecasts to 2018 Report Available Online by Researchmoz.us
6. Global Bulk Molding Compounds Market and China LOW-E Glass Analysis in New Research Added to DeepResearchReports.com
7. Monoclonal Antibodies Market in Colorectal Cancer to 2019
8. Industry Shares, Size, Trend, Analysis, and Forecasts Report Available Online by Researchmoz.us
9. MediPoint: Cardiac Rhythm Management - US Analysis and Market Forecasts
10. PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022
11. Ventana receives FDA clearance for Estrogen Receptor (ER) Image Analysis and Digital Read Application for breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... DALLAS , Oct. 10, 2017 International research firm ... IoT Strategy, will speak at the TMA 2017 Annual Meeting , ... key trends in the residential home security market and how smart safety ... ... "The ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
Breaking Biology Technology:
(Date:10/4/2017)...  GCE Solutions, a global clinical research organization (CRO), announces the ... on October 4, 2017. Shadow is designed to assist medical writers ... 0070 of the European Medicines Agency (EMA) in meeting the requirements ... ... ...
(Date:6/23/2017)... ITHACA, N.Y. , June 23, 2017 ... a leader in dairy research, today announced a new ... help reduce the chances that the global milk supply ... this dairy project, Cornell University has become the newest ... Food Supply Chain, a food safety initiative that includes ...
(Date:5/6/2017)... SINGAPORE , May 5, 2017 ... has just announced a new breakthrough in biometric ... that exploits quantum mechanical properties to perform ... new smart semiconductor material created by Ram Group ... across finance, entertainment, transportation, supply chains and security. ...
Breaking Biology News(10 mins):